vimarsana.com

Page 13 - விஞ்ஞானிகள் இல் ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How Nanotechnology is Leading the Way in Pollution Control

The Latest: EU agency: Get 2nd dose of AstraZeneca shots

WASHINGTON — Officials say the U.S. is trying to help India deal with its coronavirus surge, which is straining that country’s health care system amid a record number of infections. Dr. Anthony Fauci, the Biden administration’s top medical adviser on the pandemic, says the U.S. Centers for Disease Control and Prevention is working with its counterpart agency in India to provide technical support and assistance. India set another global record of daily infections for a second straight day with 332,730 cases. Hospitals officials are using social media, pleading with the Indian government to replenish their oxygen supplies. “It is a dire situation that we’re trying to help in any way we can,” Fauci said at the White House coronavirus briefing. “They have a situation there where there are variants that have arisen. We have not yet fully characterized the variants and the relationship between the ability of the vaccines to protect. But we’re assu

Single doses of Astrazeneca, Pfizer vaccines significantly cut COVID infection rates, confirms study

Single doses of Astrazeneca, Pfizer vaccines significantly cut COVID infection rates, confirms study 0 0 1 minute read By The Associated Press London: Scientists at Oxford University have released more data that corroborate the coronavirus vaccine made by Pfizer-BioNotech and AstraZeneca, both significantly reducing the risk of infection after a single dose. In studies published on Friday, researchers said that there was no clear difference in the ability of vaccines to reduce COVID-19 infection rates. The research has not yet been published in a peer-reviewed journal, but is based on data on nose and throat swabs taken from more than 370,000 participants in England and Wales between December and April.

Coronavirus: More data confirm single dose of two vaccines work

Scientists at Oxford University have released more data that confirm coronavirus vaccines made by Pfizer-BioNTech and AstraZeneca both significantly cut the risk of infection after a single dose. In studies published on Friday, researchers said there was no apparent difference in the vaccines ability to reduce COVID-19 infection rates. The research has not yet been published in a peer-reviewed journal but is based on data from nose and throat swabs taken from more than 370,000 participants in England and Wales between December and April. The scientists said that three weeks after people had been given a single dose of either the Pfizer-BioNTech or AstraZeneca vaccine, the rates of all COVID-19 infections fell by 65 per cent. The reduction was bigger after a second dose and the vaccines appeared to protect people against the variant that was first identified in the UK.

The Latest: WH: US will help India with surging virus cases

The Latest: Health panel urges restarting J&J vaccinations The Associated Press FacebookTwitterEmail 35 1of35People rest in the observation area, at right, after receiving COVID-19 vaccinations under the 94-foot-long, 21,000-pound model of a blue whale, in the Milstein Family Hall of Ocean Life, at the American Museum of Natural History, in New York, Friday, April 23, 2021. Appointments are no longer necessary at any of the coronavirus vaccination sites run by New York City. New York City Mayor Bill de Blasio announced Friday that anyone eligible for the vaccine could walk up to any of the city s mass vaccination sites and get a shot. The change comes as supplies of the vaccine have increased.Richard Drew/APShow MoreShow Less

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.